AGN


AbbVie Scores US Antitrust Approval for $63B Allergan Deal

AbbVie’s (ABBV) plan to close the $63 billion Allergan (AGN) deal this month appears on track following the announcement that they have received …

Barclays Has New Plays for Healthcare Fans

Investment banker Barclays announced it has initiated coverage of 20 U.S.

Mizuho Maintains Bullish View on Allergan plc Ordinary Shares (AGN) Following Positive Phase III Data Read-Out for Competitor Sun Pharmaceuticals Industries Limited (SUNPHARMA)

Mizuho analyst Irina Rivkind Koffler chimes in on Allergan plc Ordinary Shares (NYSE:AGN) on back of key competitor Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) announcing positive top-line Phase III …

Mizuho Speculates on Healthcare Giants Valeant Pharmaceuticals Intl Inc (VRX) and Allergan plc Ordinary Shares (AGN) Ahead of Earnings

Mizuho analyst Irina Rivkind Koffler is joining the earnings conversation with a preview for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Allergan plc Ordinary Shares (NYSE:AGN) as …

Analysts Mixed on Two Biotech Giants: Valeant Pharmaceuticals Intl Inc (VRX) and Allergan plc Ordinary Shares (AGN)

Amid big changes underway for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and an acquisition that has some investors raising an eyebrow at Allergan plc Ordinary Shares …

Mizuho Top Analyst Weighs in on Allergan plc Ordinary Shares (AGN) Amid Vitae Pharmaceuticals Inc (VTAE) Acquisition

Allergan plc Ordinary Shares (NYSE:AGN) announced today that it had entered an agreement to acquire Vitae Pharmaceuticals Inc (NASDAQ:VTAE), a clinical-stage biotech company, …

Stock Update (NASDAQ:VTAE): Here’s Why Vitae Pharmaceuticals Inc Shares Are Soaring 150%

Vitae Pharmaceuticals Inc (NASDAQ:VTAE) and Allergan plc (NYSE:AGN) announced that they have entered into a definitive agreement under which Allergan will acquire Vitae for $21.00 …

Credit Suisse Analyst Initiates Coverage on Allergen plc Ordinary Shares (AGN) with Outperform Rating

Credit Suisse analyst, Vamil Divan, initiates coverage on Allergen plc Ordinary Shares (NYSE:AGN) with an Outperform rating and a price target of $327.00.

Biotech’s Week Ahead: MannKind Corporation (MNKD), Allergan plc Ordinary Shares (AGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), and Horizon Pharma PLC (HZNP)

It’s an eventful week ahead for pharmaceutical companies MannKind Corporation (NASDAQ:MNKD), Allergan plc Ordinary Shares (NYSE:AGN), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Horizon Pharma PLC …

Healthcare Analysts Maintain Positive Outlook On Allergan plc Ordinary Shares (AGN) And Zafgen Inc (ZFGN) Following Recent Announcements

Healthcare analysts explain why they are bullish on Allergan plc Ordinary Shares (NYSE:AGN) and Zafgen Inc (NASDAQ:ZFGN). Although many investors are worried that …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts